A report details the usage of compounded drugs in the US, noting they are not FDA-approved and involving various entities.
2 reports, 2 independent
Updated Jul 1
Gone quiet
- Reports
- 2
- Developments
- 2
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
A report details the usage of compounded drugs in the US, noting they are not FDA-approved and involving various entities.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- FDA advises on psychoactive compound concentrations in Dutchess County.Sub-event
Report details US compounded drug usage, noting they are not FDA-approved.1 source
Keep exploring
The entities involved
-
Alliance for Pharmacy Compounding
American professional association
Nothing else this week.
- FDA
Related events
- A company is conducting clinical trials and seeking drug approval for the U.S. market under the FDA.
- Both the FDA and the Drug Enforcement Administration regulate stimulant medications.
- Both the FDA and the European Medicines Agency govern drug approval processes.
- FDA and state authorities are investigating product manufacturers in Utah.
- FDA rejected a drug application due to inadequate data, with Frances Kelsey involved in the review.